av/nath-bio-genes--big.svg

COM:NATHBIOGENES

Nath Bio-Genes (I) Ltd.

  • Stock

Last Close

177.14

14/11 09:59

Market Cap

4.75B

Beta: -

Volume Today

8.70K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
828.71M
-
1.03B
24.05%
1.29B
25.37%
1.35B
5.09%
1.27B
6.38%
1.39B
9.94%
1.80B
29.00%
2.15B
19.72%
2.23B
3.72%
2.14B
4.13%
average payables
334.39M
-
454.11M
35.80%
497.55M
9.57%
461.52M
7.24%
404.76M
12.30%
434.00M
7.22%
592.04M
36.41%
567.19M
4.20%
501.60M
11.56%
414.12M
17.44%
average receivables
493.94M
-
664.73M
34.58%
744.12M
11.94%
910.34M
22.34%
1.45B
59.83%
2.08B
43.14%
1.15B
44.68%
1.34B
16.46%
2.57B
91.53%
1.75B
32.10%
book value per share
51.10
-
66.94
31.01%
75.80
13.22%
85.97
13.42%
276.18
221.25%
267.09
3.29%
293.42
9.86%
322.71
9.98%
285.16
11.64%
301.54
5.75%
capex per share
-1.81
-
-0.44
75.61%
-13.51
2,961.53%
-2.58
80.91%
-2.86
10.93%
-11.73
310.24%
-8.53
27.32%
-6.10
28.42%
-11.06
81.18%
-1.34
87.87%
capex to depreciation
-0.62
-
-0.16
74.09%
-5.54
3,339.63%
-1.36
75.41%
-5.11
275.38%
-15.41
201.57%
-11.15
27.63%
-4.12
63.07%
-6.81
65.44%
-0.85
87.58%
capex to operating cash flow
-0.19
-
-0.10
45.74%
1.53
1,559.80%
-1.23
180.88%
0.10
108.38%
1.01
880.45%
-1.71
268.67%
-10.42
509.40%
-1.23
88.17%
-0.07
94.61%
capex to revenue
-0.02
-
-0.00
75.07%
-0.13
3,400.08%
-0.02
81.77%
-0.03
4.30%
-0.10
281.39%
-0.06
40.13%
-0.04
34.81%
-0.08
100.07%
-0.01
88.80%
cash per share
4.50
-
4.10
8.90%
3.89
5.29%
3.65
5.97%
26.17
616.43%
10.49
59.92%
11.00
4.85%
15.37
39.74%
2.19
85.73%
109.91
4,912.01%
days of inventory on hand
537.25
-
733.52
36.53%
941.97
28.42%
668.28
29.05%
531.16
20.52%
525.38
1.09%
584.44
11.24%
606.93
3.85%
648.75
6.89%
563.66
13.12%
days payables outstanding
238.17
-
323.15
35.68%
320.94
0.68%
227.74
29.04%
157.47
30.86%
169.77
7.81%
195.11
14.92%
121.31
37.82%
162.19
33.70%
75.22
53.63%
days sales outstanding
118.09
-
141.15
19.53%
173.73
23.09%
225.61
29.86%
354.45
57.11%
364.82
2.93%
318.73
-
322.12
1.06%
125.22
61.13%
debt to assets
0.11
-
0.09
16.41%
0.22
135.14%
0.24
9.05%
0.06
75.97%
0.09
57.78%
0.10
6.78%
0.12
27.27%
0.13
2.44%
0.13
5.92%
debt to equity
0.26
-
0.20
24.03%
0.48
144.93%
0.50
4.31%
0.07
86.09%
0.11
64.97%
0.13
9.82%
0.16
25.16%
0.17
8.93%
0.18
7.02%
dividend yield
0.01
-
0.01
51.03%
earnings yield
0.15
-
0.14
11.13%
0.11
19.47%
0.07
37.47%
0.04
40.77%
0.04
4.95%
0.20
359.93%
0.10
50.31%
-0.17
270.22%
0.13
178.87%
enterprise value
1.77B
-
2.06B
16.02%
1.86B
9.61%
3.00B
61.41%
7.11B
137.12%
9.37B
31.76%
3.05B
67.42%
6.38B
108.93%
4.94B
22.51%
3.36B
32.08%
enterprise value over ebitda
5.22
-
5.89
12.79%
7.38
25.29%
10.12
37.11%
16.75
65.52%
20.70
23.60%
5.43
73.76%
9.45
74.03%
12.85
35.93%
6.79
47.17%
ev to operating cash flow
11.79
-
30.43
158.10%
-13.12
143.10%
89.71
783.98%
-15.14
116.87%
-42.62
181.53%
32.22
175.61%
573.17
1,678.74%
29.00
94.94%
8.75
69.82%
ev to sales
0.94
-
1.11
18.59%
1.15
3.34%
1.77
54.17%
3.71
110.02%
4.06
9.52%
1.09
73.16%
2.08
90.27%
1.78
14.44%
1.11
37.25%
free cash flow per share
7.58
-
3.78
50.14%
-22.36
691.55%
-0.49
97.81%
-30.51
6,141.31%
-23.30
23.63%
-3.54
84.80%
-5.52
55.83%
-2.09
62.14%
18.84
1,002.05%
free cash flow yield
0.08
-
0.03
57.60%
-0.28
953.93%
-0.00
98.81%
-0.07
2,072.07%
-0.05
31.38%
-0.03
46.79%
-0.02
29.77%
-0.01
46.73%
0.13
1,462.49%
graham net net
-6.68
-
-0.11
98.37%
-6.83
6,186.25%
-1.35
80.22%
84.63
6,360.06%
69.44
17.95%
-25.93
137.34%
88.10
439.79%
51.90
41.08%
89.83
73.07%
graham number
132.14
-
154.61
17.01%
122.87
20.53%
140.28
14.17%
328.02
133.82%
348.62
6.28%
418.79
20.13%
461.16
10.12%
476.79
3.39%
354.28
25.69%
income quality
0.59
-
0.26
56.48%
-0.93
462.78%
0.20
121.46%
-1.56
883.33%
-0.57
63.81%
0.20
134.52%
0.02
89.96%
-0.27
1,471.41%
1.06
494.50%
intangibles to total assets
0.04
-
0.02
49.96%
0.01
65.26%
0
100%
0.01
Infinity%
0.01
20.43%
0.02
272.84%
0.02
16.97%
0.02
6.03%
0.01
18.94%
interest coverage
7.26
-
3.81
47.49%
1.83
51.93%
4.19
128.61%
8.55
104.07%
8.64
1.11%
8.18
5.30%
3.49
57.29%
4.59
31.30%
interest debt per share
13.14
-
15.70
19.52%
39.79
153.34%
48.63
22.22%
25.01
48.57%
33.20
32.73%
40.25
21.24%
54.97
36.59%
54.24
1.34%
60.68
11.87%
inventory turnover
0.68
-
0.50
26.76%
0.39
22.13%
0.55
40.95%
0.69
25.81%
0.69
1.10%
0.62
10.10%
0.60
3.71%
0.56
6.45%
0.65
15.10%
invested capital
0.26
-
0.20
24.03%
0.48
144.93%
0.50
4.31%
0.07
86.09%
0.11
64.97%
0.13
9.82%
0.16
25.16%
0.17
8.93%
0.18
7.02%
market cap
1.58B
-
1.86B
17.58%
1.29B
30.73%
2.37B
83.81%
7.23B
205.05%
9.00B
24.48%
2.57B
71.44%
5.71B
121.88%
4.05B
28.92%
2.68B
33.79%
net current asset value
511.01M
-
787.24M
54.06%
798.74M
1.46%
901.70M
12.89%
2.52B
179.73%
2.69B
6.53%
3.05B
13.45%
3.48B
14.05%
2.70B
22.27%
3.01B
11.46%
net debt to ebitda
0.55
-
0.55
0.02%
2.26
306.84%
2.12
6.07%
-0.28
113.42%
0.81
385.64%
0.86
5.52%
1.00
16.47%
2.31
131.24%
1.36
41.11%
net income per share
15.19
-
15.87
4.50%
8.85
44.22%
10.17
14.93%
17.31
70.19%
20.22
16.80%
26.56
31.35%
29.29
10.26%
-35.43
220.97%
18.50
152.21%
operating cash flow per share
9.39
-
4.22
55.05%
-8.85
309.72%
2.09
123.60%
-27.65
1,423.66%
-11.57
58.16%
4.99
143.09%
0.59
88.25%
8.97
1,431.59%
20.18
125.05%
payables turnover
1.53
-
1.13
26.30%
1.14
0.69%
1.60
40.92%
2.32
44.63%
2.15
7.25%
1.87
12.99%
3.01
60.83%
2.25
25.20%
4.85
115.64%
receivables turnover
3.09
-
2.59
16.34%
2.10
18.76%
1.62
22.99%
1.03
36.35%
1.00
2.84%
1.15
-
1.13
1.05%
2.91
157.25%
research and ddevelopement to revenue
0.06
-
0.07
17.56%
0.07
3.92%
0.05
25.47%
0.04
19.56%
0.01
72.89%
0.03
191.82%
0.03
8.42%
0.03
7.17%
0.03
2.56%
return on tangible assets
0.13
-
0.11
14.19%
0.05
53.38%
0.06
5.13%
0.05
7.83%
0.06
15.34%
0.07
18.06%
0.07
1.57%
-0.09
228.61%
0.04
148.72%
revenue per share
118.36
-
115.80
2.16%
101.29
12.53%
106.05
4.70%
112.79
6.35%
121.32
7.56%
147.28
21.40%
161.73
9.81%
146.46
9.44%
158.51
8.23%
roe
0.30
-
0.24
20.24%
0.12
50.73%
0.12
1.33%
0.06
47.02%
0.08
20.77%
0.09
19.57%
0.09
0.25%
-0.12
236.90%
0.06
149.38%
roic
0.24
-
0.23
2.92%
0.11
51.47%
0.08
29.13%
0.08
2.54%
0.07
8.88%
0.09
23.06%
0.09
1.57%
0.06
33.74%
0.07
11.96%
sales general and administrative to revenue
0.04
-
0.02
58.45%
0.03
56.68%
0.02
6.02%
0.03
28.63%
0.02
19.56%
0.02
25.56%
0.02
8.72%
0.02
43.14%
0.02
24.19%
shareholders equity per share
51.10
-
66.94
31.01%
75.80
13.22%
85.97
13.42%
276.18
221.25%
267.09
3.29%
293.42
9.86%
322.71
9.98%
285.16
11.64%
301.54
5.75%
stock based compensation to revenue
tangible asset value
734.84M
-
1.02B
39.07%
1.19B
16.72%
1.38B
15.35%
4.65B
238.14%
5.04B
8.33%
5.42B
7.63%
6.00B
10.55%
5.30B
11.63%
5.63B
6.19%
tangible book value per share
45.92
-
63.86
39.07%
74.53
16.72%
85.97
15.35%
273.82
218.51%
265.20
3.15%
285.44
7.63%
315.54
10.55%
278.83
11.64%
296.06
6.18%
working capital
541.65M
-
813.98M
50.28%
966.61M
18.75%
1.12B
16.12%
2.54B
126.67%
2.71B
6.55%
3.08B
13.45%
3.51B
14.09%
2.74B
22.05%
3.04B
11.29%

All numbers in (except ratios and percentages)